ERNA vs PHM · P/E 0.0, rev $582.0K vs P/E 7.7, rev $17.95B
Eterna Therapeutics Inc (ERNA) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the ERNA and PHM stock pages for the full models.
Not investment advice.